{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:12:59Z","timestamp":1793445179023,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172165"],"award-info":[{"award-number":["82172165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Young Scholar Program of Shandong Province","award":["tsqn202103171"],"award-info":[{"award-number":["tsqn202103171"]}]},{"name":"Clinical Research Foundation of Shandong Province Medical Association","award":["YXH2020ZX024"],"award-info":[{"award-number":["YXH2020ZX024"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2020T130072ZX"],"award-info":[{"award-number":["2020T130072ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Center of Shandong University","award":["2020SDUCRCC007"],"award-info":[{"award-number":["2020SDUCRCC007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00392-023-02208-1","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T14:02:44Z","timestamp":1684764164000},"page":"509-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"113","author":[{"given":"Yuliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-3976","authenticated-orcid":false,"given":"Haipeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"9","key":"2208_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.118.004905","volume":"11","author":"P Rao","year":"2018","unstructured":"Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD (2018) Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail 11(9):e004905. https:\/\/doi.org\/10.1161\/circheartfailure.118.004905","journal-title":"Circ Heart Fail"},{"issue":"12","key":"2208_CR2","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1007\/s00134-016-4536-8","volume":"42","author":"DM Ouweneel","year":"2016","unstructured":"Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstr\u00f6m AE, Lagrand WK, Cherpanath TGV, Driessen AHG, de Mol B, Henriques JPS (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42(12):1922\u20131934. https:\/\/doi.org\/10.1007\/s00134-016-4536-8","journal-title":"Intensive Care Med"},{"issue":"6","key":"2208_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/circulationaha.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, Naar J, Smalcova J, Hubatova M, Hromadka M, Volovar S, Seyfrydova M, Jarkovsky J, Svoboda M, Linhart A, Belohlavek J (2023) Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial. Circulation 147(6):454\u2013464. https:\/\/doi.org\/10.1161\/circulationaha.122.062949","journal-title":"Circulation"},{"issue":"2","key":"2208_CR4","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1161\/cir.0000000000000916","volume":"142","author":"AR Panchal","year":"2020","unstructured":"Panchal AR, Bartos JA, Caba\u00f1as JG, Donnino MW, Drennan IR, Hirsch KG, Kudenchuk PJ, Kurz MC, Lavonas EJ, Morley PT, O\u2019Neil BJ, Peberdy MA, Rittenberger JC, Rodriguez AJ, Sawyer KN, Berg KM (2020) Part 3: adult basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142(2):S366-s468. https:\/\/doi.org\/10.1161\/cir.0000000000000916","journal-title":"Circulation"},{"issue":"2","key":"2208_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s2213-2600(18)30452-1","volume":"7","author":"L Munshi","year":"2019","unstructured":"Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E (2019) Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 7(2):163\u2013172. https:\/\/doi.org\/10.1016\/s2213-2600(18)30452-1","journal-title":"Lancet Respir Med"},{"issue":"6","key":"2208_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jacc.2018.11.038","volume":"73","author":"M Guglin","year":"2019","unstructured":"Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, Gurley J, Nelson K, Malyala R, Panjrath GS, Zwischenberger JB, Pinney SP (2019) Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 73(6):698\u2013716. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.038","journal-title":"J Am Coll Cardiol"},{"key":"2208_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.686558","volume":"8","author":"A Tsangaris","year":"2021","unstructured":"Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, Yannopoulos D (2021) Overview of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the management of cardiogenic shock. Front Cardiovasc Med 8:686558. https:\/\/doi.org\/10.3389\/fcvm.2021.686558","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2208_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13054-017-1633-1","volume":"21","author":"M Smith","year":"2017","unstructured":"Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H (2017) Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the extracorporeal life support organization (ELSO) registry. Crit Care 21(1):45. https:\/\/doi.org\/10.1186\/s13054-017-1633-1","journal-title":"Crit Care"},{"issue":"3","key":"2208_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00000542-200603000-00024","volume":"104","author":"WG Toller","year":"2006","unstructured":"Toller WG, Stranz C (2006) Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 104(3):556\u2013569. https:\/\/doi.org\/10.1097\/00000542-200603000-00024","journal-title":"Anesthesiology"},{"issue":"2\u20133","key":"2208_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0014-2999(97)01108-4","volume":"333","author":"H Yokoshiki","year":"1997","unstructured":"Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N (1997) Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 333(2\u20133):249\u2013259. https:\/\/doi.org\/10.1016\/s0014-2999(97)01108-4","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2208_CR11","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1053\/j.jvca.2021.01.019","volume":"35","author":"R Kaddoura","year":"2021","unstructured":"Kaddoura R, Omar AS, Ibrahim MIM, Alkhulaifi A, Lorusso R, Elsherbini H, Soliman O, Caliskan K (2021) The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 35(8):2483\u20132495. https:\/\/doi.org\/10.1053\/j.jvca.2021.01.019","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"10","key":"2208_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5414\/cpp40465","volume":"40","author":"M Kivikko","year":"2002","unstructured":"Kivikko M, Antila S, Eha J, Lehtonen L, Pentik\u00e4inen PJ (2002) Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure. Int J Clin Pharmacol Ther 40(10):465\u2013471. https:\/\/doi.org\/10.5414\/cpp40465","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"2208_CR13","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1002\/ehf2.13427","volume":"8","author":"O Ellouze","year":"2021","unstructured":"Ellouze O, Soudry Faure A, Radhouani M, Abou-Arab O, Besnier E, Moussa M, Cransac A, Ksiazek E, Fischer MO, Mertes PM, Bouhemad B, Guinot PG (2021) Levosimendan in venoarterial ECMO weaning rational and design of a randomized double blind multicentre trial. ESC Heart Fail 8(4):3339\u20133347. https:\/\/doi.org\/10.1002\/ehf2.13427","journal-title":"ESC Heart Fail"},{"key":"2208_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2208_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"2","key":"2208_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.semtcvs.2015.07.005","volume":"27","author":"FH McCarthy","year":"2015","unstructured":"McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, Desai ND (2015) Trends in US extracorporeal membrane oxygenation use and outcomes: 2002\u20132012. Semin Thorac Cardiovasc Surg 27(2):81\u201388. https:\/\/doi.org\/10.1053\/j.semtcvs.2015.07.005","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2208_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.resuscitation.2014.09.010","volume":"86","author":"D Stub","year":"2015","unstructured":"Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, Hockings L, Shaw J, Duffy SJ, Burrell A, Cameron P (2015) Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation 86:88\u201394. https:\/\/doi.org\/10.1016\/j.resuscitation.2014.09.010","journal-title":"Resuscitation"},{"issue":"1","key":"2208_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/bja\/aew151","volume":"117","author":"K Distelmaier","year":"2016","unstructured":"Distelmaier K, Roth C, Schrutka L, Binder C, Steinlechner B, Heinz G, Lang IM, Maurer G, Koinig H, Niessner A et al (2016) Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery. Br J Anaesth 117(1):52\u201358. https:\/\/doi.org\/10.1093\/bja\/aew151","journal-title":"Br J Anaesth"},{"issue":"1","key":"2208_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-020-03122-y","volume":"24","author":"E Guilherme","year":"2020","unstructured":"Guilherme E, Jacquet-Lagreze M, Pozzi M, Achana F, Armoiry X, Fellahi J-L (2020) Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis. Crit Care 24(1):2. https:\/\/doi.org\/10.1186\/s13054-020-03122-y","journal-title":"Crit Care"},{"issue":"5","key":"2208_CR20","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1053\/j.jvca.2018.04.019","volume":"32","author":"A Jacky","year":"2018","unstructured":"Jacky A, Rudiger A, Kruger B, Wilhelm MJ, Paal S, Seifert B, Spahn DR, Bettex D (2018) Comparison of levosimendan and milrinone for ECLS weaning in patients after cardiac surgery-a retrospective before-and-after study. J Cardiothorac Vasc Anesth 32(5):2112\u20132119. https:\/\/doi.org\/10.1053\/j.jvca.2018.04.019","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"2208_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.jvca.2016.03.139","volume":"30","author":"F Sangalli","year":"2016","unstructured":"Sangalli F, Avalli L, Laratta M, Formica F, Maggioni E, Caruso R, Costa MC, Guazzi M, Fumagalli R (2016) Effects of levosimendan on endothelial function and hemodynamics during weaning from veno-arterial extracorporeal life support. J Cardiothorac Vasc Anesth 30(6):1449\u20131453. https:\/\/doi.org\/10.1053\/j.jvca.2016.03.139","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2208_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-0039-1679012","volume":"67","author":"H Deschka","year":"2019","unstructured":"Deschka H, Schafers B, Gottschalk A, Scherer M, Martens S, Welp H (2019) Effects of levosimendan therapy in patients undergoing extracorporeal membrane oxygenation after cardiac surgery. Thorac Cardiovasc Surg 67:2. https:\/\/doi.org\/10.1055\/s-0039-1679012","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"2208_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13613-019-0503-1","volume":"9","author":"S Vally","year":"2019","unstructured":"Vally S, Ferdynus C, Persichini R, Bouchet B, Braunberger E, Lo Pinto H, Martinet O, Vandroux D, Aujoulat T, Allyn J, Allou N (2019) Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit. Ann Intens Care. 9(1):2. https:\/\/doi.org\/10.1186\/s13613-019-0503-1","journal-title":"Ann Intens Care."},{"issue":"1","key":"2208_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-022-03927-z","volume":"26","author":"WS Ng","year":"2022","unstructured":"Ng WS, Tang KB, Shum HP (2022) Impact of levosimendan use on survival of patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. Crit Care 26(1):2. https:\/\/doi.org\/10.1186\/s13054-022-03927-z","journal-title":"Crit Care"},{"key":"2208_CR25","doi-asserted-by":"publisher","unstructured":"Zipfel S, Reiter B, Sill B, Barten M, Rybczinski M, Kubik M, Kluge S, Reichenspurner H, Bernhardt A (2018) Levosimendan effects benefit weaning from veno-arterial extracorporeal life support. Thoracic and cardiovascular surgeon. Conference: 47th annual meeting of the german society for thoracic and cardiovascular surgery, DGTHG 2018. Germany, 2018. 66(Supplement 1) (no pagination). https:\/\/doi.org\/10.1055\/s-0038-1628090","DOI":"10.1055\/s-0038-1628090"},{"key":"2208_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-018-1973-5","volume":"22","author":"G Haffner","year":"2018","unstructured":"Haffner G, Ajob G, Cristinar M, Marguerite S, Oulehri W, Heger B, Kindo M, Mertes PM, Steib A (2018) Levosimendan for weaning veno-arterial ECMO (VA ECMO). Crit Care 22:2. https:\/\/doi.org\/10.1186\/s13054-018-1973-5","journal-title":"Crit Care"},{"issue":"7","key":"2208_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/aor.13899","volume":"45","author":"M Alonso-Fernandez-Gatta","year":"2021","unstructured":"Alonso-Fernandez-Gatta M, Merchan-Gomez S, Gonzalez-Cebrian M, Diego-Nieto A, Alzola E, Toranzo-Nieto I, Barrio A, Martin-Herrero F, Sanchez PL (2021) Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival. Artif Organs 45(7):717\u2013725. https:\/\/doi.org\/10.1111\/aor.13899","journal-title":"Artif Organs"},{"issue":"6","key":"2208_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/MAT.0b013e3182a4b32e","volume":"59","author":"A Affronti","year":"2013","unstructured":"Affronti A, Di Bella I, Carino D, Ragni T (2013) Levosimendan may improve weaning outcomesin venoarterial ECMO patients. ASAIO J 59(6):554\u2013557. https:\/\/doi.org\/10.1097\/MAT.0b013e3182a4b32e","journal-title":"ASAIO J"},{"key":"2208_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/03913988221098773","author":"M Hau","year":"2022","unstructured":"Hau M, Fong KM, Au SY (2022) Levosimendan\u2019s effect on venoarterial extracorporeal membrane oxygenation weaning. Int J Artif Organs. https:\/\/doi.org\/10.1177\/03913988221098773","journal-title":"Int J Artif Organs"},{"issue":"1","key":"2208_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-0041-1725792","volume":"69","author":"B Florchinger","year":"2021","unstructured":"Florchinger B, Provaznik Z, Philipp A, Foltan M, Camboni D, Rupprecht L, Lunz D, Schmid C (2021) Use of levosimendan in adult patients with postcardiotomy extracorporeal life support: a single-center experience. Thorac Cardiovasc Surg 69(1):2. https:\/\/doi.org\/10.1055\/s-0041-1725792","journal-title":"Thorac Cardiovasc Surg"},{"key":"2208_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcvm.2022.912321","volume":"9","author":"Y-W Chen","year":"2022","unstructured":"Chen Y-W, Lee W-C, Wu P-J, Fang H-Y, Fang Y-N, Chen H-C, Tong M-S, Sung P-H, Lee C-H, Chung W-J (2022) Early levosimendan administration improved weaning success rate in extracorporeal membrane oxygenation in patients with cardiogenic shock. Front Cardiovasc Med 9:2. https:\/\/doi.org\/10.3389\/fcvm.2022.912321","journal-title":"Front Cardiovasc Med"},{"issue":"1 SUPPL","key":"2208_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/02676591221089240","volume":"37","author":"C Gaisendrees","year":"2022","unstructured":"Gaisendrees C, Gerfer S, Ivanov B, Sabashnikov A, Eghbalzadeh K, Djordjevic I, Wahlers T (2022) Feasibility and safety of levosimendan in patients after cardiac arrest treated with eCPR. Perfusion 37(1 SUPPL):4. https:\/\/doi.org\/10.1177\/02676591221089240","journal-title":"Perfusion"},{"issue":"27","key":"2208_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"19","key":"2208_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3238\/arztebl.2012.0343","volume":"109","author":"K Werdan","year":"2012","unstructured":"Werdan K, Ru\u00df M, Buerke M, Delle-Karth G, Geppert A, Sch\u00f6ndube FA (2012) Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German\u2013Austrian S3 guideline. Dtsch Arztebl Int 109(19):343\u2013351. https:\/\/doi.org\/10.3238\/arztebl.2012.0343","journal-title":"Dtsch Arztebl Int"},{"key":"2208_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2017.07.001","volume":"184","author":"J Qiu","year":"2017","unstructured":"Qiu J, Jia L, Hao Y, Huang S, Ma Y, Li X, Wang M, Mao Y (2017) Efficacy and safety of levosimendan in patients with acute right heart failure: a meta-analysis. Life Sci 184:30\u201336. https:\/\/doi.org\/10.1016\/j.lfs.2017.07.001","journal-title":"Life Sci"},{"issue":"3","key":"2208_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ejhf.9","volume":"16","author":"F Fedele","year":"2014","unstructured":"Fedele F, Bruno N, Brasolin B, Caira C, D\u2019Ambrosi A, Mancone M (2014) Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms. Eur J Heart Fail 16(3):281\u2013288. https:\/\/doi.org\/10.1002\/ejhf.9","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2208_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijcard.2014.04.111","volume":"174","author":"MS Nieminen","year":"2014","unstructured":"Nieminen MS, Altenberger J, Ben-Gal T, B\u00f6hmer A, Comin-Colet J, Dickstein K, Edes I, Fedele F, Fonseca C, Garc\u00eda-Gonz\u00e1lez MJ, Giannakoulas G, Iakobishvili Z, J\u00e4\u00e4skel\u00e4inen P, Karavidas A, Kettner J, Kivikko M, Lund LH, Matskeplishvili ST, Metra M, Morandi F, Oliva F, Parkhomenko A, Parissis J, Pollesello P, P\u00f6lzl G, Schwinger RH, Segovia J, Seidel M, Vrtovec B, Wikstr\u00f6m G (2014) Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. Int J Cardiol 174(2):360\u2013367. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.111","journal-title":"Int J Cardiol"},{"issue":"14","key":"2208_CR38","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2019.01.053","volume":"73","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr, Barsness GW (2019) Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock. J Am Coll Cardiol 73(14):1781\u20131791. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.053","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2208_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13054-019-2674-4","volume":"23","author":"B Cholley","year":"2019","unstructured":"Cholley B, Levy B, Fellahi JL, Longrois D, Amour J, Ouattara A, Mebazaa A (2019) Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. Crit Care 23(1):385. https:\/\/doi.org\/10.1186\/s13054-019-2674-4","journal-title":"Crit Care"},{"issue":"5","key":"2208_CR40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejheart.2005.02.002","volume":"7","author":"C Avgeropoulou","year":"2005","unstructured":"Avgeropoulou C, Andreadou I, Markantonis-Kyroudis S, Demopoulou M, Missovoulos P, Androulakis A, Kallikazaros I (2005) The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. Eur J Heart Fail 7(5):882\u2013887. https:\/\/doi.org\/10.1016\/j.ejheart.2005.02.002","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2208_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13054-020-03122-y","volume":"24","author":"E Guilherme","year":"2020","unstructured":"Guilherme E, Jacquet-Lagr\u00e8ze M, Pozzi M, Achana F, Armoiry X, Fellahi JL (2020) Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis. Crit Care 24(1):442. https:\/\/doi.org\/10.1186\/s13054-020-03122-y","journal-title":"Crit Care"},{"key":"2208_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/03913988221098773","author":"M Hau","year":"2022","unstructured":"Hau M, Fong KM, Au SY (2022) Levosimendan\u2019s effect on venoarterial extracorporeal membrane oxygenation weaning. Int J Artif Organs. https:\/\/doi.org\/10.1177\/03913988221098773","journal-title":"Int J Artif Organs"},{"issue":"2","key":"2208_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","volume":"40","author":"G Landoni","year":"2012","unstructured":"Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, Guarracino F, Zangrillo A (2012) Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med 40(2):634\u2013646. https:\/\/doi.org\/10.1097\/CCM.0b013e318232962a","journal-title":"Crit Care Med"},{"issue":"9328","key":"2208_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196\u2013202. https:\/\/doi.org\/10.1016\/s0140-6736(02)09455-2","journal-title":"Lancet"},{"issue":"10","key":"2208_CR45","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/cm9.0000000000000197","volume":"132","author":"F Feng","year":"2019","unstructured":"Feng F, Chen Y, Li M, Yuan JJ, Chang XN, Dong CM (2019) Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis. Chin Med J (Engl) 132(10):1212\u20131217. https:\/\/doi.org\/10.1097\/cm9.0000000000000197","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"2208_CR46","doi-asserted-by":"publisher","first-page":"A137","DOI":"10.1016\/j.chest.2020.05.155","volume":"157","author":"L Van De Moortel","year":"2020","unstructured":"Van De Moortel L, De Mey N, De Decker K (2020) Levosimendan after cardiac surgery: a single-center case series. Chest 157(6):A137. https:\/\/doi.org\/10.1016\/j.chest.2020.05.155","journal-title":"Chest"},{"issue":"1","key":"2208_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13054-019-2674-4","volume":"23","author":"B Cholley","year":"2019","unstructured":"Cholley B, Levy B, Fellahi JL, Longrois D, Amour J, Ouattara A, Mebazaa A (2019) Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. Crit Care 23(1):2. https:\/\/doi.org\/10.1186\/s13054-019-2674-4","journal-title":"Crit Care"},{"issue":"22","key":"2208_CR48","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1161\/circulationaha.120.048792","volume":"142","author":"B Schrage","year":"2020","unstructured":"Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, Colson P, CudemusDeseda G, Dabboura S, Eckner D, Eden M, Eitel I, Frank D, Frey N, Funamoto M, Go\u00dfling A, Graf T, Hagl C, Kirchhof P, Kupka D, Landmesser U, Lipinski J, Lopes M, Majunke N, Maniuc O, McGrath D, M\u00f6bius-Winkler S, Morrow DA, Mourad M, Noel C, Nordbeck P, Orban M, Pappalardo F, Patel SM, Pauschinger M, Pazzanese V, Reichenspurner H, Sandri M, Schulze PC (2020) Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International Multicenter Cohort Study. Circulation 142(22):2095\u20132106. https:\/\/doi.org\/10.1161\/circulationaha.120.048792","journal-title":"Circulation"},{"issue":"1","key":"2208_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101427","volume":"48","author":"S Ahmad","year":"2023","unstructured":"Ahmad S, Ahsan MJ, Ikram S, Lateef N, Khan BA, Tabassum S, Naeem A, Qavi AH, Ardhanari S, Goldsweig AM (2023) Impella versus extracorporeal membranous oxygenation (ecmo) for cardiogenic shock: a systematic review and meta-analysis. Curr Probl Cardiol 48(1):101427. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101427","journal-title":"Curr Probl Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02208-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T05:05:19Z","timestamp":1719378319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02208-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02208-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"26 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary material was mentioned in the text but it was not provided. Hence the article was published without the supplementary material. This has now been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}